Want to see HK:0348 full AI Analyst Report?
0348 Stock Chart & Stats
HK$0.14
>-HK$0.01(-2.78%)
At close: 4:00 PM EST
HK$0.14
>-HK$0.01(-2.78%)
Day’s Range― - ―
52-Week RangeHK$0.05 - HK$0.22
Previous CloseN/A
Volume850.00K
Average Volume (3M)600.74K
Market Cap
HK$67.49M
Enterprise ValueHK$115.06
Total Cash (Recent Filing)HK$22.69M
Total Debt (Recent Filing)HK$94.61M
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Mar 29, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding924,570,860
10 Day Avg. Volume379,420
30 Day Avg. Volume600,740
Financial Highlights & Ratios
PEG Ratio0.43
Price to Book (P/B)-2.72
Price to Sales (P/S)1.05
P/FCF Ratio35.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Gross MarginA positive and improving gross margin indicates that the company retains some underlying economics in its operations. If maintained, this improvement could provide a foundation for better earnings conversion, although the business still needs sufficient revenue scale and cost control to turn it into sustainable profitability.
Reduced Net LossA sharply reduced net loss shows progress in the company’s earnings trajectory and may indicate that internal performance is moving in a less adverse direction. Continued improvement would reduce the cash and capital burden of losses, though profitability has not yet been achieved.
Positive Operating Cash FlowPositive operating and free cash flow demonstrates that the business generated cash despite reported accounting losses in both 2024 and 2025. This cash conversion is a relative strength because it can support ongoing operations, although its modest scale limits its ability to address broader financial pressures.
Bears Say
Negative Shareholder EquityNegative shareholder equity signals a highly stressed capital structure and materially reduces financial flexibility. It can constrain the company’s ability to absorb further losses, support investment, or raise capital on favorable terms, making balance-sheet repair an important medium-term requirement.
Debt BurdenDebt is sizable relative to the company’s asset base, while the equity deficit makes leverage metrics especially concerning. This structure can increase financing pressure and leave less internally generated cash available for business development, particularly because cash flow remains small compared with debt.
Declining Revenue And LossesDeclining revenue limits operating leverage and makes it harder for fixed costs to be absorbed over time. Persistent losses and negative operating margins show that the improved gross margin has not yet translated into a durable earnings model, leaving the company dependent on further operational improvement.
China Healthwise Holdings News
0348 FAQ
What was China Healthwise Holdings Ltd.’s price range in the past 12 months?
China Healthwise Holdings Ltd. lowest stock price was HK$0.05 and its highest was HK$0.22 in the past 12 months.
What is China Healthwise Holdings Ltd.’s market cap?
China Healthwise Holdings Ltd.’s market cap is HK$67.49M.
When is China Healthwise Holdings Ltd.’s upcoming earnings report date?
China Healthwise Holdings Ltd.’s upcoming earnings report date is Mar 29, 2027 which is in 187 days.
How were China Healthwise Holdings Ltd.’s earnings last quarter?
China Healthwise Holdings Ltd. released its earnings results on Aug 27, 2026. The company reported -HK$0.038 earnings per share for the quarter.
Is China Healthwise Holdings Ltd. overvalued?
According to Wall Street analysts China Healthwise Holdings Ltd.’s price is currently Overvalued.
Does China Healthwise Holdings Ltd. pay dividends?
China Healthwise Holdings Ltd. does not currently pay dividends.
What is China Healthwise Holdings Ltd.’s EPS estimate?
China Healthwise Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Healthwise Holdings Ltd. have?
China Healthwise Holdings Ltd. has 924,570,860 shares outstanding.
What happened to China Healthwise Holdings Ltd.’s price movement after its last earnings report?
China Healthwise Holdings Ltd. reported an EPS of -HK$0.038 in its last earnings report. Following the earnings report the stock price went up 8.333%.
Which hedge fund is a major shareholder of China Healthwise Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:0348
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
China Healthwise Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-34.57%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
China Healthwise Holdings Ltd.
China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand. It is also involved in money lending business; and invests in financial instruments. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited was incorporated in 1997 and is headquartered in Central, Hong Kong.
Technical Analysis
New Century Healthcare Holding Co. Ltd.
―
EC Healthcare
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
UMP Healthcare Holdings Limited
―